Brian Curran Healy

Serum NfL but not GFAP predicts cognitive decline in active progressive multiple sclerosis patients.

Barro C, Healy BC, Saxena S, Glanz BI, Paul A, Polgar-Turcsanyi M, Guttmann CR, Bakshi R, Weiner HL, Chitnis T.

Mult Scler. 2022 Nov 30. 13524585221137697. PMID: 36448331

Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects.

Chitnis T, Kaskow BJ, Case J, Hanus K, Li Z, Varghese JF, Healy BC, Gauthier C, Saraceno TJ, Saxena S, Lokhande H, Moreira TG, Zurawski J, Roditi RE, Bergmark RW, Giovannoni F, Torti MF, Li Z, Quintana F, Clementi WA, Shailubhai K, Weiner HL, Baecher-Allan CM.

Front Immunol. 2022. 13:956907. PMID: 36505477

Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis.

Barro C, Healy BC, Liu Y, Saxena S, Paul A, Polgar-Turcsanyi M, Guttmann CRG, Bakshi R, Kropshofer H, Weiner HL, Chitnis T.

Neurol Neuroimmunol Neuroinflamm. 2023 01. 10(1). PMID: 36376097

A Positive Emotion-Focused Intervention to Increase Physical Activity After Bariatric Surgery: Protocol for a Pilot Randomized Controlled Trial.

Feig EH, Harnedy LE, Thorndike AN, Psaros C, Healy BC, Huffman JC.

JMIR Res Protoc. 2022 Oct 06. 11(10):e39856. PMID: 36201380

MeTooMS: Sexual, physical, and emotional abuse experience among women with multiple sclerosis.

Pol-Patil J, Glanz B, Safar L, Misasi E, Manieri MC, Shanahan R, Healy B, Houtchens M.

Mult Scler. 2022 Sep 24. 13524585221122169. PMID: 36154526

A study protocol for a double-blind randomised placebo-controlled trial evaluating the efficacy of carrageenan nasal and throat spray for COVID-19 prophylaxis-ICE-COVID.

Jessop ZM, Gibson J, Lim JY, Jovic TH, Combellack E, Dobbs TD, Carter K, Hiles S, Islam S, Healy B, Humphreys I, Eccles R, Hutchings HA, Whitaker IS.

Trials. 2022 Sep 15. 23(1):782. PMID: 36109791

Younger age at multiple sclerosis onset is associated with worse outcomes at age 50.

Bose G, Healy BC, Barro C, Glanz BI, Lokhande HA, Polgar-Turcsanyi M, Guttmann CR, Bakshi R, Weiner HL, Chitnis T.

J Neurol Neurosurg Psychiatry. 2022 Aug 11. PMID: 35953266

Latent growth curve modeling of physical activity trajectories in a positive-psychology and motivational interviewing intervention for people with type 2 diabetes.

Millstein RA, Golden J, Healy BC, Amonoo HL, Harnedy LE, Carrillo A, Celano CM, Huffman JC.

Health Psychol Behav Med. 2022. 10(1):713-730. PMID: 35957957

Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes.

Holroyd KB, Healy BC, Conway S, Houtchens M, Bakshi R, Bhattacharyya S, Bose G, Galetta K, Kaplan T, Severson C, Singhal T, Stazzone L, Zurawski J, Polgar-Turcsanyi M, Saxena S, Paul A, Glanz BI, Weiner HL, Chitnis T.

Mult Scler Relat Disord. 2022 Nov. 67:104079. PMID: 35952457

Comparison of dimethyl fumarate and interferon outcomes in an MS cohort.

Sattarnezhad N, Healy BC, Baharnoori M, Diaz-Cruz C, Stankiewicz J, Weiner HL, Chitnis T.

BMC Neurol. 2022 Jul 11. 22(1):252. PMID: 35820822